ICD-10: A65

Nonvenereal syphilis

Clinical Information

Inclusion Terms

  • Endemic syphilis
  • Bejel
  • Njovera

Additional Information

Approximate Synonyms

ICD-10 code A65 refers to Nonvenereal syphilis, a type of syphilis that is not transmitted through sexual contact. This condition is part of a broader category of diseases classified under spirochetal infections. Below are alternative names and related terms associated with ICD-10 code A65.

Alternative Names for Nonvenereal Syphilis

  1. Nonvenereal Treponematosis: This term emphasizes the non-sexual transmission of the disease, highlighting its association with the Treponema bacteria.
  2. Endemic Syphilis: Often used to describe syphilis that occurs in specific geographic areas, particularly in regions where it is more common due to environmental or social factors.
  3. Yaws: A chronic infection caused by Treponema pallidum subspecies pertenue, which is often considered a form of nonvenereal syphilis, primarily affecting the skin, bones, and joints.
  4. Pinta: Another related condition caused by Treponema carateum, which leads to skin lesions and is also classified under nonvenereal treponematoses.
  5. Bejel: Caused by Treponema pallidum subspecies endemicum, this disease is endemic in certain regions and is characterized by skin lesions and systemic involvement.
  1. Spirochetal Infections: A broader category that includes various diseases caused by spirochete bacteria, including nonvenereal syphilis and other treponematoses.
  2. Treponematoses: This term encompasses all diseases caused by Treponema species, including nonvenereal syphilis, yaws, pinta, and bejel.
  3. Congenital Syphilis: While not directly synonymous with nonvenereal syphilis, it refers to syphilis transmitted from mother to child during pregnancy, which can include nonvenereal forms.
  4. Secondary Syphilis: This term refers to the second stage of syphilis, which can occur in both venereal and nonvenereal forms, characterized by systemic symptoms and skin rashes.

Conclusion

Understanding the alternative names and related terms for ICD-10 code A65: Nonvenereal syphilis is essential for healthcare professionals, as it aids in accurate diagnosis and treatment. The terminology reflects the various forms and transmission methods of the disease, emphasizing the importance of recognizing nonvenereal syphilis within the broader context of treponemal infections.

Diagnostic Criteria

Nonvenereal syphilis, classified under ICD-10 code A65, refers to a group of syphilis infections that are not transmitted through sexual contact. This condition is primarily associated with endemic syphilis, which is prevalent in certain geographic areas and populations. The diagnosis of nonvenereal syphilis involves several criteria and considerations, which are outlined below.

Diagnostic Criteria for Nonvenereal Syphilis (ICD-10 Code A65)

1. Clinical Presentation

  • Symptoms: Patients may present with a variety of symptoms, including skin lesions, mucous membrane lesions, and systemic manifestations. The clinical features can vary widely depending on the stage of the disease.
  • Stages of Syphilis: Nonvenereal syphilis can manifest in primary, secondary, and tertiary stages, similar to venereal syphilis. Each stage has distinct clinical signs:
    • Primary Stage: Characterized by the appearance of a chancre (a painless ulcer) at the site of infection.
    • Secondary Stage: Involves systemic symptoms such as rash, fever, and lymphadenopathy.
    • Tertiary Stage: Can lead to severe complications affecting the cardiovascular system, nervous system, and other organs.

2. Serological Testing

  • Non-Treponemal Tests: These tests (e.g., RPR, VDRL) are used for initial screening. They detect antibodies that are not specific to Treponema pallidum, the bacterium causing syphilis.
  • Treponemal Tests: Confirmatory tests (e.g., FTA-ABS) that specifically detect antibodies to Treponema pallidum. A positive result in these tests supports the diagnosis of syphilis, including nonvenereal forms.

3. Epidemiological Context

  • Geographic and Demographic Factors: The diagnosis may be influenced by the patient's living conditions, travel history, and exposure to endemic areas where nonvenereal syphilis is more common. This includes populations in certain regions of Africa, Asia, and South America where the disease is endemic.

4. Exclusion of Other Conditions

  • Differential Diagnosis: It is essential to rule out other conditions that may present similarly, such as other skin infections, autoimmune diseases, or other sexually transmitted infections. A thorough clinical evaluation and history-taking are crucial.

5. History of Exposure

  • Non-Sexual Transmission: Understanding the patient's history regarding potential non-sexual transmission routes, such as contact with infected individuals or contaminated objects, is vital for diagnosis.

6. Histopathological Examination

  • In some cases, a biopsy of lesions may be performed to identify characteristic histological features of syphilis, such as the presence of plasma cell infiltrates.

Conclusion

The diagnosis of nonvenereal syphilis (ICD-10 code A65) is multifaceted, requiring a combination of clinical evaluation, serological testing, and consideration of epidemiological factors. Accurate diagnosis is essential for effective treatment and management of the disease, particularly in endemic regions where nonvenereal syphilis is prevalent. If you suspect a case of nonvenereal syphilis, it is advisable to consult with a healthcare professional for appropriate testing and diagnosis.

Description

Nonvenereal syphilis, classified under ICD-10 code A65, refers to a group of syphilis infections that are not transmitted through sexual contact. This condition is primarily associated with the transmission of the Treponema pallidum bacterium through nonsexual means, such as from mother to child during pregnancy or through direct contact with infected lesions.

Clinical Description

Overview

Nonvenereal syphilis encompasses several forms of syphilis that are not acquired through sexual intercourse. The most notable type is congenital syphilis, which occurs when a pregnant woman with syphilis transmits the infection to her fetus. This can lead to severe complications for the newborn, including physical deformities, neurological issues, and even stillbirth.

Symptoms

The symptoms of nonvenereal syphilis can vary depending on the stage of the disease and the specific type of infection. Common manifestations include:

  • Congenital Syphilis: Symptoms may include:
  • Skin rashes
  • Fever
  • Swollen liver and spleen
  • Jaundice
  • Anemia
  • Bone abnormalities

  • Other Forms: Nonvenereal syphilis can also present with lesions or rashes on the skin, mucous membranes, and other organs, depending on the route of transmission and the individual's immune response.

Diagnosis

Diagnosis of nonvenereal syphilis typically involves:

  • Serological Testing: Blood tests to detect antibodies against Treponema pallidum.
  • Clinical Evaluation: Assessment of symptoms and medical history, particularly in pregnant women or individuals with known exposure risks.

Treatment

Treatment for nonvenereal syphilis generally involves the use of antibiotics, with penicillin being the most effective option. The specific treatment regimen may vary based on the stage of the disease and the patient's overall health.

Epidemiology

Nonvenereal syphilis is less common than its venereal counterpart but remains a significant public health concern, particularly in populations with limited access to healthcare. Congenital syphilis is a particular focus, as it can lead to severe outcomes for infants if not diagnosed and treated promptly.

Conclusion

ICD-10 code A65 for nonvenereal syphilis highlights the importance of recognizing and treating this condition, especially in pregnant women to prevent transmission to the fetus. Awareness and early intervention are crucial in managing the risks associated with this infection, ensuring better health outcomes for both mothers and their children. Regular screening and education about syphilis transmission routes can help mitigate the incidence of nonvenereal syphilis in the population.

Clinical Information

Nonvenereal syphilis, classified under ICD-10 code A65, refers to a group of syphilis infections that are not transmitted through sexual contact. This condition is primarily associated with the transmission of the Treponema pallidum bacterium through nonsexual means, such as from mother to child during pregnancy or through direct contact with infected lesions. Understanding the clinical presentation, signs, symptoms, and patient characteristics of nonvenereal syphilis is crucial for effective diagnosis and management.

Clinical Presentation

Signs and Symptoms

The clinical presentation of nonvenereal syphilis can vary significantly depending on the stage of the disease. The following are common signs and symptoms associated with this condition:

  1. Primary Stage:
    - Chancre: A painless ulcer or sore at the site of infection, which may occur on the genitals, anus, or mouth. In nonvenereal cases, it can also appear on other areas of the body.
    - Lymphadenopathy: Swelling of lymph nodes near the site of the chancre.

  2. Secondary Stage:
    - Rash: A generalized rash that may appear on the trunk, arms, and legs, often resembling other skin conditions.
    - Mucous Membrane Lesions: Known as mucous membrane pemphigoid, these lesions can occur in the mouth and throat.
    - Flu-like Symptoms: Fever, malaise, and fatigue are common during this stage.

  3. Latent Stage:
    - Asymptomatic: Patients may not exhibit any symptoms, but the infection remains in the body.

  4. Tertiary Stage (if untreated):
    - Gummatous Lesions: Soft, tumor-like growths that can occur in various organs.
    - Cardiovascular Syphilis: Affects the heart and blood vessels, potentially leading to serious complications.
    - Neurosyphilis: Can cause neurological symptoms, including headaches, altered mental status, and sensory deficits.

Patient Characteristics

Patients with nonvenereal syphilis may present with specific characteristics that can aid in diagnosis:

  • Demographics: Nonvenereal syphilis can affect individuals of any age, but certain populations, such as infants born to infected mothers, are at higher risk.
  • History of Exposure: A history of contact with infected individuals, particularly in nonsexual contexts (e.g., shared personal items or mother-to-child transmission), is significant.
  • Immunocompromised Status: Individuals with weakened immune systems may be more susceptible to infections, including nonvenereal syphilis.
  • Geographic and Socioeconomic Factors: Higher prevalence may be observed in certain geographic areas or among populations with limited access to healthcare.

Diagnosis and Management

Diagnosis of nonvenereal syphilis typically involves serological testing to detect antibodies against Treponema pallidum. Common tests include:

  • Non-treponemal Tests: Such as the Rapid Plasma Reagin (RPR) or Venereal Disease Research Laboratory (VDRL) tests, which indicate the presence of syphilis but are not specific.
  • Treponemal Tests: Such as the FTA-ABS (Fluorescent Treponemal Antibody Absorption) test, which confirms the diagnosis.

Management of nonvenereal syphilis primarily involves antibiotic treatment, with penicillin being the most effective option. The treatment regimen may vary based on the stage of the disease and the patient's overall health.

Conclusion

Nonvenereal syphilis, while less commonly discussed than its venereal counterpart, presents a significant public health concern. Understanding its clinical presentation, signs, symptoms, and patient characteristics is essential for timely diagnosis and treatment. Awareness of the disease's transmission routes and risk factors can help healthcare providers implement effective prevention strategies and improve patient outcomes. Regular screening and education about syphilis, including nonvenereal forms, are vital components of public health initiatives aimed at reducing the incidence of this infection.

Treatment Guidelines

Nonvenereal syphilis, classified under ICD-10 code A65, refers to a group of syphilis infections that are not transmitted through sexual contact. This condition can manifest in various forms, including congenital syphilis and other nonsexual transmission routes. Understanding the standard treatment approaches for this condition is crucial for effective management and prevention of complications.

Overview of Nonvenereal Syphilis

Nonvenereal syphilis can occur through several mechanisms, including congenital transmission from mother to child during pregnancy or through contact with infected lesions. The clinical presentation may vary, but it often includes symptoms similar to those of venereal syphilis, such as skin rashes, mucous membrane lesions, and systemic symptoms.

Standard Treatment Approaches

1. Antibiotic Therapy

The primary treatment for nonvenereal syphilis is antibiotic therapy, with penicillin being the most effective and widely recommended option. The specific regimen may vary based on the stage of the disease and the patient's clinical condition:

  • Benzathine Penicillin G: This is the first-line treatment for all stages of syphilis, including nonvenereal forms. The typical dosage for adults is 2.4 million units administered intramuscularly in a single dose for early syphilis. For late latent syphilis, the treatment may involve three doses of 2.4 million units at weekly intervals[1][2].

  • Alternative Antibiotics: For patients who are allergic to penicillin, alternatives such as doxycycline or tetracycline may be used. Doxycycline is typically administered at a dose of 100 mg twice daily for 14 days for early syphilis and for 28 days for late latent syphilis[3].

2. Monitoring and Follow-Up

After initiating treatment, it is essential to monitor the patient for clinical improvement and serological response. Follow-up serological testing is recommended at 6 and 12 months post-treatment to ensure that the infection has been adequately treated and to check for any potential reinfection[4].

3. Management of Complications

In cases where nonvenereal syphilis has led to complications, such as neurological involvement or cardiovascular issues, additional interventions may be necessary. This could include:

  • Cerebrospinal Fluid (CSF) Analysis: For patients with neurological symptoms, a lumbar puncture may be performed to assess for neurosyphilis, which would require more intensive treatment, often with higher doses of penicillin[5].

  • Supportive Care: Patients may also require symptomatic treatment for any associated complications, such as skin lesions or systemic symptoms.

4. Preventive Measures

Preventing nonvenereal syphilis, particularly congenital syphilis, involves ensuring that pregnant women receive appropriate prenatal care, including screening for syphilis. Early detection and treatment of syphilis in pregnant women can significantly reduce the risk of transmission to the fetus[6].

Conclusion

The management of nonvenereal syphilis primarily revolves around effective antibiotic therapy, with penicillin being the cornerstone of treatment. Regular monitoring and follow-up are crucial to ensure successful outcomes and to manage any complications that may arise. Preventive strategies, particularly in pregnant women, play a vital role in reducing the incidence of this condition. For healthcare providers, staying informed about the latest guidelines and treatment protocols is essential for optimal patient care.


References

  1. ICD-10 International statistical classification of diseases and related health problems.
  2. Guidebook on treatment protocols for syphilis.
  3. Sepsis ICD Coding Validation Study.
  4. Predicting congenital syphilis cases: A performance analysis.
  5. International Statistical Classification of Diseases - 10th Revision.
  6. Guidelines for the prevention of congenital syphilis.

Related Information

Approximate Synonyms

  • Nonvenereal Treponematosis
  • Endemic Syphilis
  • Yaws
  • Pinta
  • Bejel

Diagnostic Criteria

  • Patients present with skin lesions
  • Mucous membrane lesions and systemic manifestations
  • Primary stage: chancre at site of infection
  • Secondary stage: rash, fever, lymphadenopathy
  • Tertiary stage: cardiovascular, nervous system damage
  • Non-Treponemal tests for initial screening
  • Treponemal tests confirm diagnosis with specificity
  • Geographic and demographic factors in diagnosis
  • Exclusion of other conditions through differential diagnosis
  • History of exposure to non-sexual transmission routes
  • Histopathological examination in some cases

Description

  • Not transmitted through sexual contact
  • Primarily associated with mother-to-child transmission
  • Can be transmitted through direct contact with infected lesions
  • Congenital syphilis occurs when mother transmits infection
  • Symptoms include skin rashes, fever, and organ problems
  • Diagnosis involves serological testing and clinical evaluation
  • Treatment is antibiotics, typically penicillin

Clinical Information

  • Painless ulcer or sore appears
  • Lymph nodes swell near chancre site
  • Generalized rash occurs on trunk and limbs
  • Mucous membrane lesions in mouth and throat
  • Fever, malaise, fatigue in secondary stage
  • Asymptomatic patients have latent infection
  • Gummatous lesions form if untreated
  • Cardiovascular syphilis can cause serious complications
  • Neurosyphilis causes headaches, altered mental status
  • Individuals of any age can be affected
  • Certain populations are at higher risk due to contact history
  • Immunocompromised individuals are more susceptible
  • Higher prevalence in certain geographic areas

Treatment Guidelines

  • Antibiotic therapy is primary treatment
  • Penicillin is most effective and widely recommended
  • Benzathine Penicillin G for early syphilis
  • 3 doses weekly for late latent syphilis
  • Doxycycline alternative for penicillin allergy
  • Follow-up serological testing at 6 and 12 months
  • Monitor clinical improvement and serological response
  • Cerebrospinal Fluid (CSF) analysis for neurological symptoms
  • Supportive care for associated complications

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.